GLOW Tri-Peptide TB-500 + BPC-157 + GHK-Cu 20 mg / 20 mg / 30 mg
Description
Biochem GLOW Tri-Peptide TB-500 + BPC-157 + GHK-Cu 20 mg / 20 mg / 30 mg – Peptide Blend
Biochem GLOW Tri-Peptide 20 mg / 20 mg / 30 mg is a three-component peptide formulation combining TB-500, BPC-157, and GHK-Cu (Copper Peptide). These compounds have been studied for their biological properties associated with cellular signaling, tissue repair pathways, extracellular matrix regulation, and connective tissue maintenance.
TB-500 is commonly associated with thymosin beta-4, a naturally occurring peptide involved in actin regulation, cellular migration, and tissue-associated biological processes. Commercial products labeled TB-500 may contain different thymosin beta-4-related sequences, making confirmation of the exact peptide identity important.
BPC-157, also known as Body Protection Compound 157, is a synthetic pentadecapeptide composed of 15 amino acids. It has been examined in experimental models involving tendon and ligament tissue, skeletal muscle, gastrointestinal tissue, and cellular responses to injury.
GHK-Cu, commonly known as Copper Peptide or Copper Tripeptide-1, is a copper-binding complex formed from the tripeptide glycyl-L-histidyl-L-lysine (GHK) and copper(II). It has been studied for its effects on collagen-associated pathways, fibroblast activity, skin biology, and extracellular matrix regulation.
The GLOW combination brings together three compounds with distinct molecular structures and biological activities. Although their individual properties have been examined in experimental studies, the combined biological effects and clinical outcomes of this exact three-peptide formulation have not been established.
Unlike anabolic-androgenic steroids or growth hormone secretagogues, these peptides are not primarily characterized by direct androgen receptor activation or stimulation of growth hormone secretion.
The Biochem GLOW Tri-Peptide formulation contains a labeled quantity of 20 mg TB-500, 20 mg BPC-157, and 30 mg GHK-Cu per vial, providing 70 mg of combined peptide and peptide-complex content. The precise TB-500 sequence, excipients, physical presentation, and manufacturing specifications have not been independently verified.
| Specification | Details |
|---|---|
| Product Name | Biochem GLOW Tri-Peptide |
| Alternative Names | GLOW Peptide Blend / TB-500 + BPC-157 + GHK-Cu |
| Active Ingredients | TB-500, BPC-157, and GHK-Cu |
| Strength | 20 mg TB-500 + 20 mg BPC-157 + 30 mg GHK-Cu |
| Total Active Ingredients | 70 mg per vial |
| Blend Ratio | 2:2:3 by Mass |
| Peptide Classification | Thymosin Beta-4-Related Peptide + Pentadecapeptide + Copper Tripeptide Complex |
| TB-500 Classification | Thymosin Beta-4-Related Peptide |
| BPC-157 Classification | Synthetic Pentadecapeptide |
| GHK-Cu Classification | Copper-Binding Tripeptide Complex |
| BPC-157 Amino Acid Length | 15 Amino Acids |
| BPC-157 Amino Acid Sequence | GEPPPGKPADDAGLV |
| GHK Amino Acid Sequence | Gly-His-Lys |
| GHK-Cu Copper Component | Copper(II) Ion (Cu²⁺) |
| TB-500 Molecular Identity | Exact Sequence Not Confirmed |
| Vial Size | Not Specified |
| Formulation | Not Confirmed |
| Compound Classification | Multi-Peptide Blend |
| Primary Area of Study | Tissue Repair, Cellular Signaling, and Extracellular Matrix Biology |
| Biological Activity | Effects on Tissue-Associated Cellular Pathways |
| Administration | Formulation-Dependent |
| Release Profile | Dependent on Individual Peptide Characteristics and Formulation |
1. Influences Tissue Repair Pathways
TB-500-related peptides, BPC-157, and GHK-Cu have individually been examined for their effects on biological pathways associated with tissue repair. Experimental findings include changes in cellular migration, tissue organization, and signaling processes involved in responses to injury. These findings do not establish equivalent effects for the combined formulation.
2. Influences Cellular Migration and Organization
Thymosin beta-4 is associated with actin regulation, a biological process involved in cellular structure and movement. Thymosin beta-4-related peptides have been examined for their effects on cellular migration and tissue organization in experimental models.
3. Influences Tendon and Ligament Tissue
BPC-157 has been studied in animal models involving tendon and ligament injury. These studies have examined fibroblast activity, collagen-associated processes, and cellular responses involved in connective tissue maintenance.
4. Influences Collagen and Extracellular Matrix Regulation
GHK-Cu has been examined for its effects on collagen-associated pathways and extracellular matrix components. These processes contribute to the structural organization of skin and connective tissue.
5. Influences Vascular Signaling Pathways
BPC-157 and thymosin beta-4-related peptides have been studied in experimental models involving vascular signaling and angiogenesis-associated processes. These findings concern biological responses observed under specific experimental conditions.
6. Exhibits Copper-Binding Properties
GHK-Cu contains a tripeptide capable of coordinating copper(II) ions. Copper participates in several physiological processes, including the activity of enzymes associated with connective tissue metabolism. The copper-binding characteristics of GHK-Cu distinguish it from the other two components of the blend.
7. Combines Distinct Peptide Structures
The GLOW formulation combines a thymosin beta-4-related peptide, a 15-amino-acid pentadecapeptide, and a copper-binding tripeptide complex. These components have different biochemical characteristics and may interact with different cellular pathways. Their combined effectiveness, compatibility, and long-term safety have not been established in controlled human studies.
The biological effects of the GLOW Tri-Peptide blend depend on the identity and purity of each component, the formulation, exposure, and individual physiological response. Most evidence concerning TB-500-related peptides and BPC-157 comes from preclinical models, while evidence for GHK-Cu is more developed in certain topical skin applications than in systemic administration.
Biochem GLOW Tri-Peptide combines three peptide-based components associated with different aspects of cellular signaling and tissue biology. Its pharmacological profile cannot be determined simply by adding together findings from studies of the individual compounds.
Step 1 – Introduction Into the Biological System
TB-500, BPC-157, and GHK-Cu enter the biological environment according to the formulation and route of administration. Their absorption and availability depend on the physical and chemical properties of the preparation.
Step 2 – Thymosin Beta-4-Related Cellular Interaction
Thymosin beta-4 participates in actin-associated cellular processes, including mechanisms involved in cell movement and organization. The activity of a product labeled TB-500 depends on its exact peptide sequence and molecular identity.
Step 3 – BPC-157 Cellular Signaling Interaction
BPC-157 has been examined for its effects on cellular signaling pathways associated with tissue responses to injury, fibroblast activity, and vascular regulation. Its precise primary molecular target has not been conclusively established.
Step 4 – GHK-Cu Copper and Extracellular Matrix Interaction
GHK-Cu interacts with biological systems through its peptide structure and copper-binding characteristics. Experimental studies have examined its effects on fibroblast activity, collagen-associated processes, and extracellular matrix regulation.
Step 5 – Peptide Metabolism and Elimination
The components of the GLOW blend undergo biological distribution, degradation, and clearance according to their molecular characteristics. The peptide components are subject to proteolytic processes, while copper participates in physiological transport and elimination pathways.
A validated elimination half-life for the specified Biochem GLOW Tri-Peptide 20 mg / 20 mg / 30 mg formulation has not been established. The individual pharmacokinetic characteristics of TB-500, BPC-157, and GHK-Cu should not be assumed to remain unchanged when combined in a single preparation.
Multi-peptide formulations differ from conventional single-peptide preparations because they contain multiple compounds with distinct chemical properties, stability characteristics, and potential interactions.
Their formulation characteristics may include:
- Three peptide-based components in one formulation.
- A labeled quantity of 20 mg of TB-500 per vial.
- A labeled quantity of 20 mg of BPC-157 per vial.
- A labeled quantity of 30 mg of GHK-Cu per vial.
- A combined active content of 70 mg per vial.
- Lyophilized or liquid presentations, depending on the formulation.
- Excipients selected to support peptide stability and compatibility.
- Packaging and storage requirements determined by the product composition.
The precise formulation, TB-500 molecular identity, and excipient composition of Biochem GLOW Tri-Peptide 70 mg have not been confirmed.
Formulation ingredients do not independently produce the biological effects associated with the three active components.
United States
Biochem GLOW Tri Peptide 70mg, Biochem GLOW 20mg 20mg 30mg USA, GLOW peptide blend United States, TB-500 BPC-157 GHK-Cu blend, TB500 20mg BPC157 20mg GHK-Cu 30mg, GLOW Tri Peptide 70mg vial, GLOW peptide properties, GLOW peptide description, GLOW peptide how it works, GLOW peptide composition, GLOW peptide pharmacology, TB-500 cellular migration, BPC-157 tissue repair pathways, GHK-Cu collagen pathways, copper peptide GLOW blend, GLOW extracellular matrix, GLOW connective tissue biology, GLOW peptide mechanism of action, three peptide combination.
Canada
English: Biochem GLOW Tri Peptide 70mg Canada, GLOW peptide blend Canada, TB-500 20mg BPC-157 20mg GHK-Cu 30mg, GLOW 70mg vial Canada, GLOW peptide properties, GLOW peptide formulation, TB-500 cellular signaling, BPC-157 tissue pathways, GHK-Cu collagen pathways, copper peptide blend, GLOW peptide composition.
French: Biochem GLOW Tri-Peptide 70 mg Canada, mélange de peptides GLOW Canada, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, flacon GLOW 70 mg, propriétés du mélange GLOW, composition des peptides, réparation des tissus, signalisation cellulaire, matrice extracellulaire, peptide de cuivre GHK-Cu, mécanisme d'action GLOW.
United Kingdom
Biochem GLOW Tri Peptide 70mg UK, GLOW peptide blend UK, TB-500 20mg BPC-157 20mg GHK-Cu 30mg, GLOW 70mg vial UK, GLOW peptide properties, GLOW peptide pharmacology, tissue repair pathways, cellular migration, collagen-associated pathways, copper peptide GHK-Cu, GLOW peptide composition, GLOW mechanism of action.
Germany
Biochem GLOW Tri-Peptid 70 mg Deutschland, GLOW Peptidmischung 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg Fläschchen, GLOW Peptid Eigenschaften, GLOW Wirkungsmechanismus, GLOW Zusammensetzung, Gewebereparatur, Zellmigration, Kollagenstoffwechsel, extrazelluläre Matrix, GHK-Cu Kupferpeptid.
France
Biochem GLOW Tri-Peptide 70 mg France, mélange de peptides GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, flacon GLOW 70 mg, propriétés du GLOW, mécanisme d'action GLOW, composition du mélange, réparation tissulaire, migration cellulaire, collagène, matrice extracellulaire, peptide de cuivre GHK-Cu.
Spain
Biochem GLOW Tripéptido 70 mg España, mezcla de péptidos GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, cómo funciona GLOW, composición de GLOW, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, mecanismo de acción GLOW.
Italy
Biochem GLOW Tri-Peptide 70 mg Italia, miscela di peptidi GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, flaconcino GLOW 70 mg, proprietà del GLOW, meccanismo d'azione GLOW, composizione del GLOW, riparazione dei tessuti, migrazione cellulare, sintesi del collagene, matrice extracellulare, peptide di rame GHK-Cu.
Portugal
Biochem GLOW Tri-Peptide 70 mg Portugal, mistura de peptídeos GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, frasco GLOW 70 mg, propriedades do GLOW, mecanismo de ação GLOW, composição do GLOW, reparação de tecidos, migração celular, síntese de colagénio, matriz extracelular, peptídeo de cobre GHK-Cu.
Netherlands
Biochem GLOW Tri Peptide 70 mg Nederland, GLOW peptidemengsel 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg flacon, eigenschappen van GLOW, werkingsmechanisme GLOW, samenstelling van GLOW, weefselherstel, celmigratie, collageensynthese, extracellulaire matrix, GHK-Cu koperpeptide.
Belgium
Biochem GLOW Tri Peptide 70 mg Belgium, GLOW peptidemengsel België, mélange de peptides GLOW Belgique, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg flacon, eigenschappen van GLOW, propriétés du GLOW, weefselherstel, réparation tissulaire, celmigratie, migration cellulaire, collageen, collagène, koperpeptide, peptide de cuivre.
Switzerland
Biochem GLOW Tri Peptide 70 mg Switzerland, GLOW Peptidmischung Schweiz, mélange de peptides GLOW Suisse, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg Fläschchen, GLOW 70 mg flacon, Gewebereparatur, réparation tissulaire, Zellmigration, migration cellulaire, Kollagensynthese, synthèse du collagène, Kupferpeptid GHK-Cu.
Austria
Biochem GLOW Tri-Peptid 70 mg Österreich, GLOW Peptidmischung 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg Fläschchen, GLOW Eigenschaften, GLOW Wirkungsmechanismus, Gewebereparatur, Zellmigration, Kollagensynthese, extrazelluläre Matrix, GHK-Cu Kupferpeptid.
Sweden
Biochem GLOW Tri Peptide 70 mg Sverige, GLOW peptidblandning 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg injektionsflaska, GLOW egenskaper, GLOW verkningsmekanism, vävnadsreparation, cellmigration, kollagensyntes, extracellulär matrix, GHK-Cu kopparpeptid.
Norway
Biochem GLOW Tri Peptide 70 mg Norge, GLOW peptidblanding 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg hetteglass, GLOW egenskaper, GLOW virkningsmekanisme, vevsreparasjon, cellemigrasjon, kollagensyntese, ekstracellulær matriks, GHK-Cu kobberpeptid.
Denmark
Biochem GLOW Tri Peptide 70 mg Danmark, GLOW peptidblanding 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg hætteglas, GLOW egenskaber, GLOW virkningsmekanisme, vævsreparation, cellemigration, kollagensyntese, ekstracellulær matrix, GHK-Cu kobberpeptid.
Finland
Biochem GLOW Tri Peptide 70 mg Suomi, GLOW peptidiseos 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, GLOW 70 mg injektiopullo, GLOW ominaisuudet, GLOW vaikutusmekanismi, kudosten korjaantuminen, solujen liikkuminen, kollageenisynteesi, soluväliaine, GHK-Cu kuparipeptidi.
Poland
Biochem GLOW Tri Peptide 70 mg Polska, mieszanka peptydów GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, fiolka GLOW 70 mg, właściwości GLOW, mechanizm działania GLOW, skład GLOW, regeneracja tkanek, migracja komórek, synteza kolagenu, macierz zewnątrzkomórkowa, peptyd miedziowy GHK-Cu.
Czech Republic
Biochem GLOW Tri Peptide 70 mg Česko, směs peptidů GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, lahvička GLOW 70 mg, vlastnosti GLOW, mechanismus účinku GLOW, složení GLOW, obnova tkání, buněčná migrace, syntéza kolagenu, extracelulární matrix, měďnatý peptid GHK-Cu.
Romania
Biochem GLOW Tri Peptide 70 mg România, amestec de peptide GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, flacon GLOW 70 mg, proprietăți GLOW, mecanism de acțiune GLOW, compoziția GLOW, repararea țesuturilor, migrarea celulară, sinteza colagenului, matrice extracelulară, peptidă de cupru GHK-Cu.
Greece
Biochem GLOW Tri Peptide 70 mg Ελλάδα, μείγμα πεπτιδίων GLOW 70 mg, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, φιαλίδιο GLOW 70 mg, ιδιότητες GLOW, μηχανισμός δράσης GLOW, σύνθεση GLOW, αποκατάσταση ιστών, κυτταρική μετανάστευση, σύνθεση κολλαγόνου, εξωκυττάρια θεμέλια ουσία, πεπτίδιο χαλκού GHK-Cu.
Ireland
Biochem GLOW Tri Peptide 70mg Ireland, GLOW peptide blend Ireland, TB-500 20mg BPC-157 20mg GHK-Cu 30mg, GLOW 70mg vial Ireland, GLOW peptide properties, GLOW peptide pharmacology, tissue repair pathways, cellular migration, collagen-associated pathways, copper peptide GHK-Cu, GLOW peptide composition, GLOW mechanism of action.
Colombia
Biochem GLOW Tri-Peptide 70 mg Colombia, mezcla de péptidos GLOW 70 mg Colombia, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, cómo funciona GLOW, farmacología del GLOW, composición del GLOW, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, mecanismo de acción del GLOW, descripción de la mezcla de péptidos.
Argentina
Biochem GLOW Tri-Peptide 70 mg Argentina, mezcla de péptidos GLOW 70 mg Argentina, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, qué es GLOW Tri-Peptide, cómo actúa GLOW, farmacología de los péptidos, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, composición del GLOW.
México
Biochem GLOW Tri-Peptide 70 mg México, mezcla de péptidos GLOW 70 mg México, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, para qué se estudia GLOW Tri-Peptide, cómo funciona GLOW, farmacología del GLOW, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, mecanismo de acción del GLOW.
Perú
Biochem GLOW Tri-Peptide 70 mg Perú, mezcla de péptidos GLOW 70 mg Perú, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, qué es GLOW Tri-Peptide, cómo funciona GLOW, farmacología del GLOW, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, composición del GLOW.
Venezuela
Biochem GLOW Tri-Peptide 70 mg Venezuela, mezcla de péptidos GLOW 70 mg Venezuela, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, qué es GLOW Tri-Peptide, cómo actúa GLOW, farmacología del GLOW, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, composición del GLOW.
Ecuador
Biochem GLOW Tri-Peptide 70 mg Ecuador, mezcla de péptidos GLOW 70 mg Ecuador, TB-500 20 mg BPC-157 20 mg GHK-Cu 30 mg, vial GLOW 70 mg, propiedades del GLOW, para qué se estudia GLOW Tri-Peptide, cómo funciona GLOW, farmacología del GLOW, reparación de tejidos, migración celular, síntesis de colágeno, matriz extracelular, péptido de cobre GHK-Cu, composición del GLOW, mecanismo de acción del GLOW, descripción de GLOW Tri-Peptide.
Biochem GLOW Tri-Peptide 70mg | TB-500 + BPC-157 + GHK-Cu
Learn about Biochem GLOW Tri-Peptide 70mg, combining TB-500 20mg, BPC-157 20mg, and GHK-Cu 30mg, including composition, cellular signaling, and tissue-associated biological properties.
Biochem GLOW Tripéptido 70mg | TB-500 + BPC-157 + GHK-Cu
Conoce Biochem GLOW Tripéptido 70mg, con TB-500 20mg, BPC-157 20mg y GHK-Cu 30mg, su composición y propiedades biológicas relacionadas con los tejidos y la señalización celular.
biochem-glow-tri-peptide-tb500-bpc157-ghk-cu-70mg
biochem-glow-tripeptido-tb500-bpc157-ghk-cu-70mg
Biochem GLOW Tri-Peptide 70mg vial containing TB-500 20mg, BPC-157 20mg, and GHK-Cu Copper Peptide 30mg, a three-component peptide blend associated with cellular signaling, connective tissue biology, and extracellular matrix pathways.
Biochem GLOW Tripéptido 70mg vial que contiene TB-500 20mg, BPC-157 20mg y GHK-Cu péptido de cobre 30mg, una mezcla de tres componentes relacionada con la señalización celular, el tejido conectivo y la matriz extracelular.